Date Name Title Filing Type Shares Traded Price Total Held
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 3,500 -- 8,500
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,000 -- 500
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 500 -- --
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,626 -- --
May 05, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 20,000 $7.44 32,530
May 05, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Open market or private sale of non-derivative or derivative security 20,000 $13.50 12,530
May 05, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Open market or private sale of non-derivative or derivative security 2,000 $13.50 10,530
May 05, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 20,000 -- 15,000
Dec 11, 2020
VP Controller
VP Controller Form 4 Other acquisition or disposition -- -- 1,432
Dec 11, 2020
VP Controller
VP Controller Form 4 Other acquisition or disposition -- -- 1,897

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.